Cardiovascular Diseases clinical trials
The registry lists 5,372 studies for Cardiovascular Diseases across more than 10 countries. 940 are recruiting or about to start. 2,072 of them are mainly about Cardiovascular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 251 narrower conditions too, such as Stroke: 69,284 studies, 15,032 open.
ClinicalTrials.gov finds 67,371 studies for Cardiovascular Diseases. How that becomes 5,370 here
This page counts the studies the registry files under Cardiovascular Diseases, and those it files under no condition that list Cardiovascular Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count
- 67,371Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −59,126Filed under a narrower condition, counted on its own pageStroke 7,595 · Heart Failure 5,225 · Hypertension 5,023 · Coronary Artery Disease 4,203 · Multiple Myeloma 3,664 · Atrial Fibrillation 3,151 · 231 more
- −92List Cardiovascular Diseases as a condition, but the registry did not file them under itMost often written as “Cardiovascular Disease Risk Factors” (7), “Cardiovascular Disease Risk Factor” (7), and “Cardiovascular Disease Risk” (6). The registry filed 42 of them under no condition at all, and the others under other conditions only, most often Obesity (11) and Motor Activity (9).
- −2,783Match it another way318 name it in the title, 53 in a keyword, and 2,412 by a synonym or other text the search reads.
- 5,370The count on this page
Get an email when these change. Save the Cardiovascular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
National Heart, Lung, and Blood Institute (NHLBI) (493) · Brigham and Women's Hospital (45) · VA Office of Research and Development (44) · Duke University (42) · University of Toronto (39) · AstraZeneca (39) · Penn State University (37) · University of Pennsylvania (36)
What is being tested here
Drugs under test in Cardiovascular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Aspirin | 7 | 7 | 40 |
| Rivaroxaban | 7 | 2 | 12 |
| Semaglutide | 6 | 1 | 7 |
| Colchicine | 5 | 3 | 11 |
| Omega-3 fatty acid | 3 | 6 | 17 |
| Metformin | 3 | 1 | 15 |
| Empagliflozin | 3 | 0 | 8 |
| Inclisiran | 3 | 4 | 6 |
| Atorvastatin | 2 | 4 | 36 |
| Fish Oils | 2 | 1 | 11 |
Drug classes tested here SGLT2 inhibitors 9 open · NSAIDs 7 open · Factor Xa inhibitors 7 open · Statins 6 open · GLP-1 receptor agonists 6 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Nov 2026Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs · Phase 3 · Penn State University
- Dec 2026Colchicine and Inflammation in Aortic Stenosis · Phase 3 · Radboud University Medical Center
- Dec 2026A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension · Phase 3 · United Therapeutics
- Dec 2026CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes · Phase 3 · VA Office of Research and Development
- Jan 2027PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis · Phase 3 · University of Alabama at Birmingham
- Jan 2027A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event · Phase 3 · AstraZeneca
- Sep 2027REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels · Phase 3 · Novo Nordisk A/S
- Oct 2027VITAL Rhythm Study · Phase 3 · Brigham and Women's Hospital
- Nov 2026The Cooking for Health Optimization and Disease Prevention (CHOP) Trial · Tulane University
- Nov 2026Zenith® Fenestrated+ Clinical Study · Cook Research Incorporated
Who these studies take
Of the 668 Cardiovascular Diseases studies recruiting now, 390 (58%) set no upper age limit and 142 (21%) stop at 75 or younger. 77 (12%) take children under 18. 33 (5%) are for women only and 6 (1%) for men only; 175 (26%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 67 (10%) | 66 (10%) |
| 18 | 463 (69%) | 450 (67%) |
| 30 | 527 (79%) | 509 (76%) |
| 40 | 585 (88%) | 562 (84%) |
| 50 | 610 (91%) | 590 (88%) |
| 65 | 610 (91%) | 592 (89%) |
| 75 | 555 (83%) | 543 (81%) |
| 85 | 472 (71%) | 462 (69%) |
Across all 5,372 studies, recruiting or not: 30% stop at 75 or younger and 17% at 65; 18% take children; 6% are for women only and 9% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Cardiovascular Diseases studies take
Of 113 phase 4 interventional studies under Cardiovascular Diseases, half reached primary completion within 46 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 15 mo3–45 · 96 studies | 3 mo1–15 · 53 studies | 45 mo17–67 · 43 studies |
| Phase 1/2 | 40 mo34–62 · 20 studies | — | — |
| Phase 2 | 28 mo16–61 · 84 studies | — | 38 mo23–73 · 60 studies |
| Phase 3 | 57 mo34–83 · 82 studies | 48 mo29–79 · 42 studies | 57 mo41–95 · 40 studies |
| Phase 4 | 46 mo26–64 · 113 studies | — | 46 mo28–76 · 107 studies |
| Interventional, no phase | 26 mo12–49 · 1,218 studies | 26 mo15–53 · 139 studies | 26 mo12–48 · 1,079 studies |
| Observational | 61 mo24–192 · 666 studies | 31 mo14–48 · 84 studies | 71 mo29–196 · 582 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting10
- Master Study Protocol for the Cohort of the Specialty Network Stroke (SN Stroke)(Stroke-CORE)Nov 17, 2026NCT07553650
- A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart FailureNov 12, 2026NCT07584967
- A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseNov 10, 2026NCT07839936
- NightWare and Cardiovascular Health in Women With PTSDNov 6, 2026NCT07021014
- Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 DiabetesNov 5, 2026NCT07479329
Show 5 moreShow fewer
- Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement SystemNov 2, 2026NCT07687485
- Vasopressor Agents in Pulmonary Hypertension CrisisOct 30, 2026NCT07667829
- Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk FactorsOct 22, 2026NCT06796582
- TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)Oct 21, 2026NCT07684313
- Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney DiseaseOct 20, 2026NCT07141628
Results posted3
- Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator ReplacementNov 9, 2026NCT02668900
- Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVTNov 6, 2026NCT07554170
- TRISCEND JAPAN StudyOct 27, 2026NCT05760989
Stopped1
- An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)TerminatedNov 10, 2026NCT05900141
Newly registered17
- ACOUSTIC-1: Acoustic Sensing of Cardiopulmonary HemodynamicsNov 17, 2026NCT07940894
- Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular RiskNov 12, 2026NCT07930975
- Prospective Cohort Study of Patients Undergoing Coronary Angiography in Vorarlberg, AustriaNov 12, 2026NCT07932327
- High-Intensity Functional Training vs. Moderate-Intensity Continuous Training in Cardiovascular Disease PatientsNov 10, 2026NCT07929701
- A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseaseNov 5, 2026NCT07918846
Show 12 moreShow fewer
- PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)Nov 4, 2026NCT07916883
- Long-Term Clinical, Health Economic, and Process Evaluation of Intensive Technology-Integrated Motor Rehabilitation in Chronic Neurological Conditions (INTeRAcT-bis)Nov 3, 2026NCT07912320
- Real-World Validation of A Minimally Disruptive Ambulatory Blood Pressure Monitoring (ABPM) Huawei Smartwatch in MalaysiaNov 3, 2026NCT07913607
- Threshold-Based Versus Range-Based Exercise Intensity Prescription in Cardiac RehabilitationNov 2, 2026NCT07908810
- Cardiovascular Disease MultimorbidityNov 2, 2026NCT07909395
- Impact of a Tailored Digital Intervention on Sedentary Behaviour and Physical Health in Long-term Cardiac Rehabilitation PatientsNov 2, 2026NCT07910812
- Relationship Between Insulin Dose and Complications in Type 1 DiabetesNov 2, 2026NCT07911033
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
- Wearable Ultrasound for Cardiac Monitoring During Surgery and in Intensive CareOct 23, 2026NCT07891052
- Reducing Arterial Inflammation Using Eplerenone and Statins in HIVOct 23, 2026NCT07892664
- Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity RisksOct 21, 2026NCT07884903
- EValuation of prognostIc and Cost reDuction by tElemonitoring iN CIEDs Usual carE: an Updated Analysis Using 2019-2023 DataOct 19, 2026NCT07881250
Studies
Recruiting first, then most recently updated. Showing 50 of 5,372. Browse all 5,372 → or search them.
- Cardiometabolic Effects of Low-Fat and Full-Fat DairyNot yet recruitingNCT07605442Not applicable
- RESOLving INflammation Through Diet for Health (RESOLVIN)RecruitingNCT07331103Not applicable1 country
- Effects of Physical Activity, Ambulatory Blood Pressure and Calcium Score on Cardiovascular Health in Normal PeopleRecruitingNCT027911521 country
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskNot yet recruitingNCT07900633Phase 321 countries
- Hyperpolarized MR Imaging With Carbon-13 Pyruvate in the Human BodyRecruitingNCT06645691Phase 21 country
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.Not yet recruitingNCT06458907Not applicable1 country
- SHADES Mechanistic TrialEnrolling by invitationNCT06041581Not applicable1 country
- Master Study Protocol for the Cohort of the Specialty Network Stroke (SN Stroke)(Stroke-CORE)RecruitingNCT075536501 country
- ACOUSTIC-1: Acoustic Sensing of Cardiopulmonary HemodynamicsNot yet recruitingNCT07940894
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular DiseaseRecruitingNCT07843472Phase 33 countries
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular EventsRecruitingNCT07136012Phase 34 countries
- Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient CareRecruitingNCT04877197Not applicable1 country
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionRecruitingNCT06909565Phase 41 country
- Sleep Hygiene Education in Individuals With Cardiovascular Disease: Effects on Sleep Quality and Disease ManagementNot yet recruitingNCT07135921Not applicable
- Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in RussiaRecruitingNCT068583321 country
- Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial FibrillationRecruitingNCT06938412Not applicable1 country
- New Onset of Arrhythmia After Patent Foramen Ovale (PFO) ClosureRecruitingNCT069836131 country
- A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart FailureRecruitingNCT07584967Phase 28 countries
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruitingNCT07064473Phase 351 countries
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery LesionsRecruitingNCT07258290Not applicable4 countries
- INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryRecruitingNCT06965504Not applicable1 country
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseRecruitingNCT07181109Phase 335 countries
- Community Health Worker-Led Intervention to Increase Cardiac Rehabilitation ParticipationRecruitingNCT06908590Not applicable1 country
- Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) ProgramRecruitingNCT06784895Not applicable1 country
- Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular RiskNot yet recruitingNCT079309751 country
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy VolunteersRecruitingNCT04216342Phase 11 country
- PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)Not yet recruitingNCT079168831 country
- Clinical and Molecular Characteristics of Primary Aldosteronism in BlacksRecruitingNCT033742151 country
- Redirecting Poor Sleep Drivers of Early Cardiovascular DiseaseRecruitingNCT069497221 country
- HYPERtension Reduction Through WALKing Stairs Versus Brisk WalkingRecruitingNCT06952348Not applicable1 country
- Prospective Cohort Study of Patients Undergoing Coronary Angiography in Vorarlberg, AustriaRecruitingNCT079323271 country
- High-Intensity Functional Training vs. Moderate-Intensity Continuous Training in Cardiovascular Disease PatientsNot yet recruitingNCT07929701Not applicable1 country
- Study to Determine the Clinical Significance of Intravascular OCT-NIRAFEnrolling by invitationNCT06374498Not applicable1 country
- Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular GraftsRecruitingNCT04467671Phase 21 country
- Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIVRecruitingNCT06001814Not applicable1 country
- A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)RecruitingNCT07286578Not applicable4 countries
- A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart DiseaseRecruitingNCT07214376Not applicable2 countries
- A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseRecruitingNCT07839936Phase 21 country
- VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)RecruitingNCT07516444Not applicable1 country
- Gut Microbiota in Metabolic SurgeryRecruitingNCT050009961 country
- Natural History Study of CADASILRecruitingNCT050724831 country
- Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.RecruitingNCT066019981 country
- NightWare and Cardiovascular Health in Women With PTSDRecruitingNCT07021014Not applicable1 country
- Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)RecruitingNCT07601425Phase 1/22 countries
- Beta-Blocker Influences on Inflammatory and Neural Responses to StressRecruitingNCT06263452Phase 41 country
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureRecruitingNCT06526195Not applicable8 countries
- Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney TransplantationRecruitingNCT062344101 country
- The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary PreventionEnrolling by invitationNCT05677386Not applicable1 country
- Truway Diagnostic Tools in Primary CareEnrolling by invitationNCT07209527Early Phase 11 country
- A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseaseNot yet recruitingNCT07918846Phase 3